Lobar pneumonia caused by Ralstonia pickettii in a sixty-five-year-old Han Chinese man: a case report

Related Experiment Videos

Wensen Pan1, Zhiming Zhao, Mei Dong

  • 1Department of Reproductive Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang, China. pwszzmxx@sina.com.cn.

Abstract

Insights

This case highlights Ralstonia pickettii pneumonia and abscess in an older patient without a clear hospital-acquired source. Further research is needed to understand its antibiotic sensitivity for emerging infections.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Ralstonia pickettii is an emerging gram-negative pathogen often linked to nosocomial infections.
  • Human infections with Ralstonia pickettii unrelated to contaminated solutions are rare.
  • This study focuses on a community-acquired case of Ralstonia pickettii infection.

Purpose of the Study:

  • To report a rare case of lobar pneumonia and pulmonary abscess caused by Ralstonia pickettii.
  • To describe the clinical presentation, diagnosis, and treatment of this infection.
  • To emphasize the need for further investigation into Ralstonia pickettii antibiotic sensitivities.

Main Methods:

  • A case presentation of a sixty-five-year-old male with symptoms of pneumonia.
  • Diagnostic procedures included thoracic CT scan, lung biopsy, and thoracentesis.
  • Microbiological analysis confirmed Ralstonia pickettii in lung biopsy and abscess fluid.
  • Treatment involved a course of intravenous antibiotics (cefoperazone sodium-sulbactam sodium and imipenem-cilastatin).

Main Results:

  • Ralstonia pickettii was identified as the causative agent of lobar pneumonia and a subsequent pulmonary abscess.
  • The patient successfully recovered after a course of broad-spectrum antibiotics and chest tube drainage.
  • Clinical and radiological resolution of pneumonia and abscess was observed post-treatment.

Conclusions:

  • This case illustrates a Ralstonia pickettii infection occurring without an apparent nosocomial origin.
  • The increasing incidence of such infections suggests a need for heightened awareness.
  • Further studies are crucial to determine the antibiotic susceptibility patterns of Ralstonia pickettii.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: